The Additional Use of Viral Entry Inhibitors during Autologous Hematopoietic Stem Cell Transplantation in Patients with Non-Hodgkin Lymphoma and HIV-1 Infection

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 4, 2011, Pages 586-587

  Hütter, Gero ^a   Allers, Kristina ^a   Schneider, Thomas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; VIRUS RNA;

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CD4+ T LYMPHOCYTE; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LETTER; NONHODGKIN LYMPHOMA; NONHUMAN; T LYMPHOCYTE ACTIVATION; VIRUS LOAD;

ANTIVIRAL AGENTS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; TRANSPLANTATION, AUTOLOGOUS; VIRUS INTERNALIZATION;

EID: 79952625499     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.10.030     Document Type: Letter

References (8)

1. Wang C., Vlahov D., Galai N., et al. Mortality in HIV-seropositive versus-seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. J Infect Dis 2004, 190:1046-1054.
2. Perelson A.S., Essunger P., Cao Y., et al. Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 1997, 387:188-191.
3. Schneider T., Ullrich R., Zeitz M. Immunopathology of human immunodeficiency virus infection in the gastrointestinal tract. Springer Semin Immunopathol 1997, 18:515-533.
4. Finzi D., Blankson J., Siliciano J.D., et al. Latent infection of CD4 + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 1999, 5:512-517.
5. Hutter G., Nowak D., Mossner M., et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med 2009, 360:692-698.
6. Krishnan A. Stem cell transplantation in HIV-infected patients. Curr Opin HIV AIDS 2009, 4:11-15.
7. Carter N.J., Keating G.M. Maraviroc. Drugs 2007, 67:2277-2288. discussion 2289-2290.
8. An D.S., Donahue R.E., Kamata M., et al. Stable reduction of CCR5 by RNAi through hematopoietic stem cell transplant in non-human primates. Proc Natl Acad Sci USA 2007, 104:13110-13115.